Tirzepatide causes nausea in slightly higher numbers of patients initially because its GIP+GLP-1 dual action is more potent, but the difference is modest and nausea typically resolves within 4-8 weeks
A notable clinical trial involving oral semaglutide ( Rybelsus ) showed substantial weight loss in participants over 68 weeks
Sanchez-Rodriguez et al., 2020
Thnh phn: L-glutathione 98 %
facilitating over-stimulated or sustained inflammatory responses with interferon and cytokine release, influencing ROS production, iron storage, platelet coagulability, cytokine production stimulation, regulation of fission and fusion, mitochondrial biogenesis, and interference of apoptosis and mitophagy (312319)
3 Personalized treatment plan You're started on a low dose (typically 0.25mg semaglutide weekly) with a titration schedule